©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2010; 16(46): 5830-5837
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830
Published online Dec 14, 2010. doi: 10.3748/wjg.v16.i46.5830
Table 4 Histological features in the fatty liver diseases cohort
| Cases of fatty liver disease (n = 363) | n (%) |
| Steatosis | |
| S0 | 9 (2.5) |
| S1 | 169 (46.6) |
| S2 | 84 (23.1) |
| S3 | 101 (27.8) |
| Ballooning | |
| No ballooning | 164 (45.2) |
| Stage 1 | 124 (34.2) |
| Stage 2 | 75 (20.7) |
| Inflammation | |
| G0 | 4 (1.1) |
| G1 | 217 (59.8) |
| G2 | 113 (31.1) |
| G3 | 29 (8) |
| Fibrosis | |
| F0 | 97 (26.7) |
| F1 | 116 (32) |
| F2 | 66 (18.2) |
| F3 | 56 (15.4) |
| F4 | 28 (7.7) |
- Citation: Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Hausen AZ, Dienes HP, Drebber U, Odenthal M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010; 16(46): 5830-5837
- URL: https://www.wjgnet.com/1007-9327/full/v16/i46/5830.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i46.5830